Eikon Therapeutics

We seek to advance breakthrough therapeutics through the purposeful integration of engineering and science. At Eikon, we discover and develop new medicines by reimagining what is possible — inventing new technologies to bring to light quantitati ting new technologies to bring to light quantitative information about the behavior of biological systems — to identify new targets and bring novel therapies to patients. We are a team of research scientists, engineers, clinical scientists, and data scientists with deep expertise and accomplishments, working together to combine science and advanced engineering to create innovative therapies that will improve and extend life. We are endlessly curious, intellectually honest and thrive in exploring biology in new ways. As experienced researchers and clinicians, we apply traditional, high-performance tools when we can. And our engineering skills allow us to build new instruments when we need them. With this approach we explore cell and molecular biology in completely new ways. There is a direct link between protein motion and activity. By measuring the dynamics of protein populations, we can explore the activity of novel pharmaceuticals in great detail. With our proprietary single-molecule tracking (SMT) platform, we can visualize hundreds of thousands of protein motion events in living cells in less than 
a second. By integrating AI capabilities and advanced automation together with SMT, 
we can inventory molecular interactions with extraordinary scale and precision. Protein activity is mediated by transient interactions between a protein molecule and other components of the cellular environment, including membranes, other proteins, DNA/RNA and small molecules. These transient interactions define the motion profile of a protein population. By precisely measuring these motions, we describe the activities and the functions of a protein.